Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) had its target price lowered by equities research analysts at Canaccord Genuity Group from $7.00 to $6.50 in a research note issued on Thursday, ...

George Gianarikas, Canaccord Genuity analyst, joins CNBC's 'Squawk on the Street' to discuss outlooks on Tesla.

Archer Aviation (NYSE:ACHR – Free Report) had its price objective reduced by Canaccord Genuity Group from $14.00 to $13.00 in ...

Canaccord Genuity has downgraded Pliant (PLRX) to hold following news that the company has paused a clinical trial for its ...

Global (NYSE:SPIR) shares, bringing it down from $24.00 to $11.50, while maintaining a Buy rating on the stock. Currently trading at $10.12, the stock has experienced significant volatility, with ...

In a report released today, Robert Young from Canaccord Genuity maintained a Buy rating on Dye & Durham (DND – Research Report), with a ...

Aurora Innovation, Inc. (NASDAQ: AUR) today announced David Maday, Chief Financial Officer, will participate in a virtual ...

Vertex Pharmaceuticals (VRTX) stock gets an upgrade from Canaccord Genuity after its Q4 2024 results on Tuesday, Read more here.

A big dividend yield for a few years doesn't mean much if it can't be sustained. While Canaccord Genuity Group is not profitable, it is paying out less than 75% of its free cash flow, which means that ...

Canaccord Genuity analyst Alexander Bedwany reiterated a Sell rating on South32 Ltd. (S32 – Research Report) yesterday and set a price target ...

Uncertainty around North American trade has hindered capital-markets activity and stalled investments in Canada, according to Canaccord Genuity Group Inc. Chief Executive Officer Daniel Daviau ...

Analysts at Canaccord Genuity slightly raised their target price on Celtic from 202.0p to 208.0p on Tuesday, stating the firm ...